ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
Technology

SoftBank invests $900m more in Nasdaq-listed US gene tech maker

Pacific Biosciences shares soar following latest fundraising from Japanese group

SoftBank Group has focused more on public companies recently, looking to diversify its investments. (Photo by Yoichi Iwata)
TAKAFUMI HOTTA, Nikkei staff writer | Japan

TOKYO -- Japan's SoftBank Group will invest $900 million in a U.S. developer of equipment for genetic analysis, building on its earlier investment in the company.

Nasdaq-listed Pacific Biosciences of California said Wednesday that SoftBank Group agreed to buy convertible bonds through subsidiary SB Management.

Read Next

Latest On Technology

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more

By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our Cookie Policy to learn how you can update your cookie settings.

Accept & Continue Close